United Kingdom· GB-APID-34595811000001109
Tecentriq 1200mg/20ml solution for infusion vials
A atezolizumab product containing atezolizumab, registered in United Kingdom by Imported (United States). The same ATC class is registered in 14 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Atezolizumab is registered in 14 of 19 countries.
Countries holding a registration under ATC L01FF05 (atezolizumab), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 8 of them publish a price we can compare per daily dose
Atezolizumab · ATC L01FF05
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of atezolizumab costs, country by country.
Normalised to the WHO defined daily dose (89 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Atezolizumab · price per daily dose (89 mg)
USD · FX 28 Sept 2026
- CH Switzerland$377.53
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Atezolizumab
- Manufacturer
- Imported (United States)
- Country
- United Kingdom (GB)
- ATC code
- L01FF05
- ATC class
- Atezolizumab
- Defined daily dose
- 89 mg, P
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
75 interactions on record for atezolizumab.
Graded by severity as the source publishes them — 30 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Atezolizumab · interactions on record
75 records
- 30 severe
- 45 moderate
Most severe, free to view
- CladribineL01BB04severe
- Talimogene laherparepvecL01XL02severe
- Talimogen laherparepvecL01XX51severe
- LeflunomidL04AA13severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Atezolizumab in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainTECENTRIQ 1.200 MG CONCENTRADO PARA SOLUCION PARA PERFUSIONRoche Registration Gmbh
- FinlandTecentriqAbacus Medicine A/S
- NorwayTecentriqAbacus Medicine A/S
- FranceTECENTRIQ 1 875 mg, solution injectableROCHE REGISTRATION (ALLEMAGNE)
- IrelandTecentriq 1200 mg concentrate for solution for infusionRoche Registration GmbH
- IcelandTecentriqRoche Registration GmbH*
- NetherlandsTecentriq 1200 mg concentraat voor oplossing voor infusievoor infusieRoche Registration GmbH
- BelgiumTecentriq 1200 mgRoche Registration
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Tecentriq
- Liechtenstein · Tecentriq
- Norway · Tecentriq
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/aefc9a63-9a21-4a49-99aa-09da05af7b1b GET /v1/drugs/aefc9a63-9a21-4a49-99aa-09da05af7b1b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "34595811000001109",
"desc": "Tecentriq 1200mg/20ml solution for infusion vials (Imported (United States))",
"form": "Solution for infusion",
"vpid": "34595611000001105",
"source": "dmd",
"vtm_id": "774689009",
"strength": "60 mg",
"substance": "Atezolizumab",
"ingredient": "Atezolizumab",
"supplier_code": "11821411000001108"
}See everything about atezolizumab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.